Open AccessSerum galectin-3 level predicts early recurrence following successful direct current cardioversion in persistent atrial fibrillation patients.
Author(s) -
Kadri Murat Gürses,
Muhammed Ulvi Yalçın,
Duygu Koçyiğit,
Hande Canpınar,
Ahmet Hakan Ateş,
Uğur Canpolat,
Hikmet Yorgun,
Dicle Güç,
Kudret Aytemir
Publication year - 2019
Publication title -
türk kardiyoloji derneği arşivi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 24
ISSN - 1016-5169
DOI - 10.5543/tkda.2019.58399
Subject(s) - cardiology , medicine , atrial fibrillation , cardioversion , galectin 3
Atrial structural remodeling has been suggested to contribute to atrial fibrillation (AF) recurrence following direct-current cardioversion (DCCV). The role of several inflammatory and extracellular matrix turnover markers in AF recurrence following DCCV has been investigated. However, data on the impact of galectin-3, which is known to play a role in various fibrotic conditions, including cardiac fibrosis are lacking. The aim of this study was to demonstrate the predictive role of serum galectin-3 levels in AF recurrence following successful DCCV.